(Journal Article): Type 2 Diabetes – Failure, Blame and Guilt in the Adoption of Insulin Therapy
 
Phillips P (Department of Endocrinology, The Queen Elizabeth Hospital, 28 Woodville Road, Woodville SA 5011, Australia, patrick.phillips(at)nwahs.sa.gov.au )
 
IN: Rev Diabetic Stud 2005; 2(1):35-39
Impact Factor(s) of Rev Diabetic Stud: 0.125 (2006)

Fulltext:    HTML  PDF

ABSTRACT: Type 2 Diabetes is a progressive disease with an insidious onset, including decreased first-phase insulin secretion and mild forms of hyperinsulinemia caused by heterogenous factors such as genetic make-up, obesity and lifestyle. Decreased insulin secretion may already be a first sign of beta-cell damage, which is expected to develop into insulin resistance later and to result in progressive beta-cell deterioration and death. The disease has become highly prevalent in Western countries and is rapidly reaching epidemic proportions in the developing world. While the molecular mechanisms involved in the etiology of this disease remain relatively poorly understood, the United Kingdom Prospective Diabetes Study (UKPDS) has clearly demonstrated in several investigations that the adoption of insulin therapy in early phases of the disease is capable of attenuating or even preventing massive beta-cell loss and thus the severe metabolic syndrome and its late complications. This report aims to highlight the common psychological obstacles healthcare professionals are faced with when they are attempting early introduction of insulin therapy. Many patients typically underrate early signs and repress the fact that the disease is developing while they are vainly attempting to keep to lifestyle changes like New Year’s resolutions. However, there is also reluctance on the part of the healthcare professionals. At the same time, patients’ reservations about needles and fear of hypoglycemia can be removed simply by educating patients about the relatively low risk of hypoglycemia. Coupled with enhanced healthcare services, this strategy can overcome psychological insulin resistance and contribute to the maintenance of good metabolic control.

TYPE OF PUBLICATION: Case Report

REFERENCES:

1. Korytkowski M. When oral agents fail: practical barriers to starting insulin. Int J Obes Relat Metab Disord 2002. 26 Suppl 3:S18-24. [DOD]
2. Muller DC, Elahi D, Tobin JD, Andres R. The effect of age on insulin resistance and secretion: a review. Semin Nephrol 1996. 16(4):289-298. [DOD]
3. Kaneto H, Nakatani Y, Kawamori D, Miyatsuka T, Matsuoka TA. Involvement of oxidative stress and the JNK pathway in glucose toxicity. Rev Diabetic Stud 2004. 1(4):163-172. [DOD]
4. Isomaa B. A major health hazard: the metabolic syndrome. Life Sci 2003. 73(19):2395-2411. [DOD]
5. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998. 352(9131):837-853. [DOD]
6. Turner RC, Cull CA, Frighi V, Holman RR. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group. JAMA 1999. 281(21):2005-2012. [DOD]
7. Wittmann I, Soltesz G, Jermendy G, Nagy J. Decreased first-phase secretion of insulin may play a role in the development of insulin resistance. Orv Hetil 2004. 145(45):2267-72. [DOD]
8. Phillipov G, Phillips PJ. Components of total measurement error for hemoglobin A(1c) determination. Clin Chem 2001. 47(10):1851-1853. [DOD]
9. Peyrot M, Mathews DR, Snoek FJ, Calogiuri R, Kleinebreil L, Rubin R, Ishii H, Lauritzen T, Geelhoed-Duijvestijn PH, Skovlund SE. An international study of physiological insulin resistance to insulin use among persons with diabetes. 18th International Diabetes Federation Congress, August 24-29 2003, Paris, France. OP Education 5: Psychological insulin resistance. [DOD]
10. Phillips P, MacLennan A. HRT – is it for me? Case studies in HRT. RACGP Check Programme, October, 1998. [DOD]
11. Phillips P, Carapetis M. Eat less, walk more. Enjoyable eating for type 2 diabetes. Aust Fam Physician 2002. 31(12):1065-1071. [DOD]